| heterochromatin organization | GO:0070828 | 25 | 0.774 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 277 | 0.765 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 77 | 0.580 | |
| negative regulation of biosynthetic process | GO:0009890 | 277 | 0.540 | |
| negative regulation of rna metabolic process | GO:0051253 | 251 | 0.515 | |
| negative regulation of cellular metabolic process | GO:0031324 | 382 | 0.427 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 240 | 0.405 | |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 240 | 0.361 | |
| positive regulation of transcription dna templated | GO:0045893 | 266 | 0.356 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 270 | 0.339 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 332 | 0.334 | |
| chromosome organization | GO:0051276 | 360 | 0.294 | Human |
| transcription from rna polymerase ii promoter | GO:0006366 | 368 | 0.249 | |
| protein alkylation | GO:0008213 | 43 | 0.243 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 378 | 0.236 | |
| chromatin silencing | GO:0006342 | 76 | 0.196 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 261 | 0.195 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.186 | |
| negative regulation of transcription dna templated | GO:0045892 | 237 | 0.167 | |
| segmentation | GO:0035282 | 207 | 0.165 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 283 | 0.157 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 267 | 0.155 | |
| regulation of intracellular signal transduction | GO:1902531 | 236 | 0.153 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 316 | 0.145 | |
| regulation of cellular component biogenesis | GO:0044087 | 201 | 0.140 | |
| chromatin organization | GO:0006325 | 207 | 0.126 | Human |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 266 | 0.126 | |
| positive regulation of rna biosynthetic process | GO:1902680 | 266 | 0.122 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 265 | 0.121 | |
| positive regulation of biosynthetic process | GO:0009891 | 316 | 0.116 | |
| negative regulation of gene expression | GO:0010629 | 387 | 0.112 | |
| macromolecule methylation | GO:0043414 | 45 | 0.104 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 204 | 0.100 | |
| regionalization | GO:0003002 | 416 | 0.100 | |
| blastoderm segmentation | GO:0007350 | 159 | 0.099 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 80 | 0.097 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 405 | 0.097 | |
| oocyte differentiation | GO:0009994 | 145 | 0.097 | |
| regulation of ras protein signal transduction | GO:0046578 | 93 | 0.095 | |
| histone methylation | GO:0016571 | 40 | 0.095 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 93 | 0.088 | |
| dna packaging | GO:0006323 | 91 | 0.082 | |
| small gtpase mediated signal transduction | GO:0007264 | 88 | 0.081 | |
| ras protein signal transduction | GO:0007265 | 88 | 0.080 | |
| positive regulation of response to stimulus | GO:0048584 | 323 | 0.077 | |
| regulation of transcription by chromatin organization | GO:0034401 | 3 | 0.075 | |
| positive regulation of rna metabolic process | GO:0051254 | 271 | 0.075 | |
| covalent chromatin modification | GO:0016569 | 106 | 0.075 | |
| chromatin remodeling | GO:0006338 | 72 | 0.074 | Human |
| regulation of chromatin modification | GO:1903308 | 28 | 0.073 | |
| regulation of gene expression epigenetic | GO:0040029 | 128 | 0.071 | |
| embryonic axis specification | GO:0000578 | 107 | 0.070 | |
| cellular catabolic process | GO:0044248 | 372 | 0.070 | |
| regulation of gene silencing | GO:0060968 | 63 | 0.066 | |
| regulation of chromosome organization | GO:0033044 | 64 | 0.065 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 119 | 0.065 | |
| nucleobase containing compound catabolic process | GO:0034655 | 165 | 0.064 | |
| regulation of phosphate metabolic process | GO:0019220 | 210 | 0.063 | |
| regulation of chromatin organization | GO:1902275 | 32 | 0.063 | |
| positive regulation of phosphate metabolic process | GO:0045937 | 139 | 0.063 | |
| histone lysine methylation | GO:0034968 | 32 | 0.062 | |
| dna methylation or demethylation | GO:0044728 | 4 | 0.062 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 103 | 0.060 | |
| mitotic dna damage checkpoint | GO:0044773 | 74 | 0.059 | |
| aromatic compound catabolic process | GO:0019439 | 166 | 0.058 | |
| chromatin assembly | GO:0031497 | 48 | 0.058 | |
| methylation | GO:0032259 | 47 | 0.057 | |
| gene silencing | GO:0016458 | 138 | 0.057 | |
| histone h3 k4 methylation | GO:0051568 | 16 | 0.056 | |
| anterior posterior pattern specification | GO:0009952 | 136 | 0.054 | |
| meiotic dna double strand break formation | GO:0042138 | 1 | 0.052 | |
| organic substance catabolic process | GO:1901575 | 308 | 0.051 | |
| intracellular signal transduction | GO:0035556 | 300 | 0.051 | |
| regulation of organelle organization | GO:0033043 | 196 | 0.050 | |
| cellular macromolecule catabolic process | GO:0044265 | 136 | 0.050 | |
| cellular ketone metabolic process | GO:0042180 | 24 | 0.047 | |
| positive regulation of gene expression | GO:0010628 | 290 | 0.047 | |
| phosphorylation | GO:0016310 | 294 | 0.045 | |
| regulation of cell differentiation | GO:0045595 | 302 | 0.044 | |
| appendage morphogenesis | GO:0035107 | 397 | 0.044 | |
| positive regulation of signaling | GO:0023056 | 243 | 0.044 | |
| cellular macromolecular complex assembly | GO:0034622 | 153 | 0.043 | |
| dna integrity checkpoint | GO:0031570 | 81 | 0.042 | |
| histone modification | GO:0016570 | 106 | 0.041 | |
| imaginal disc derived leg morphogenesis | GO:0007480 | 80 | 0.041 | |
| regulation of phosphorylation | GO:0042325 | 147 | 0.040 | |
| embryonic pattern specification | GO:0009880 | 174 | 0.039 | |
| positive regulation of cell communication | GO:0010647 | 250 | 0.039 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 3 | 0.038 | |
| mitotic chromosome condensation | GO:0007076 | 22 | 0.038 | |
| cellular protein modification process | GO:0006464 | 438 | 0.037 | |
| heterocycle catabolic process | GO:0046700 | 166 | 0.037 | |
| organic cyclic compound catabolic process | GO:1901361 | 168 | 0.036 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 130 | 0.036 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 0 | 0.035 | |
| mitotic cell cycle checkpoint | GO:0007093 | 88 | 0.035 | |
| cellular macromolecule localization | GO:0070727 | 220 | 0.034 | |
| leg disc morphogenesis | GO:0007478 | 80 | 0.034 | |
| cellular response to dna damage stimulus | GO:0006974 | 223 | 0.033 | |
| oocyte construction | GO:0007308 | 112 | 0.032 | |
| regulation of chromatin silencing | GO:0031935 | 36 | 0.032 | |
| signal transduction by phosphorylation | GO:0023014 | 107 | 0.032 | |
| organonitrogen compound metabolic process | GO:1901564 | 318 | 0.032 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 165 | 0.031 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 3 | 0.031 | |
| sister chromatid segregation | GO:0000819 | 92 | 0.031 | |
| mitotic dna integrity checkpoint | GO:0044774 | 75 | 0.031 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 69 | 0.031 | |
| neurological system process | GO:0050877 | 358 | 0.031 | |
| erk1 and erk2 cascade | GO:0070371 | 39 | 0.031 | |
| regulation of protein metabolic process | GO:0051246 | 256 | 0.030 | |
| meiotic cell cycle process | GO:1903046 | 132 | 0.029 | |
| dna metabolic process | GO:0006259 | 227 | 0.029 | |
| g2 dna damage checkpoint | GO:0031572 | 69 | 0.029 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 103 | 0.028 | |
| chromatin assembly or disassembly | GO:0006333 | 52 | 0.028 | |
| dendrite development | GO:0016358 | 204 | 0.027 | |
| protein methylation | GO:0006479 | 43 | 0.027 | |
| small molecule metabolic process | GO:0044281 | 305 | 0.027 | |
| regulation of mapk cascade | GO:0043408 | 92 | 0.027 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 108 | 0.027 | |
| positive regulation of cellular component organization | GO:0051130 | 156 | 0.026 | |
| dna conformation change | GO:0071103 | 105 | 0.026 | |
| positive regulation of phosphorus metabolic process | GO:0010562 | 139 | 0.026 | |
| negative regulation of small gtpase mediated signal transduction | GO:0051058 | 13 | 0.026 | |
| atp dependent chromatin remodeling | GO:0043044 | 22 | 0.025 | Human |
| chromatin modification | GO:0016568 | 147 | 0.025 | Human |
| positive regulation of intracellular signal transduction | GO:1902533 | 116 | 0.025 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 179 | 0.025 | |
| regulation of phosphorus metabolic process | GO:0051174 | 210 | 0.024 | |
| macromolecule catabolic process | GO:0009057 | 161 | 0.024 | |
| meiotic cell cycle | GO:0051321 | 171 | 0.023 | |
| cell cycle checkpoint | GO:0000075 | 95 | 0.023 | |
| anterior posterior axis specification | GO:0009948 | 109 | 0.023 | |
| mapk cascade | GO:0000165 | 107 | 0.022 | |
| stem cell division | GO:0017145 | 69 | 0.022 | |
| establishment or maintenance of cell polarity | GO:0007163 | 167 | 0.022 | |
| catabolic process | GO:0009056 | 409 | 0.022 | |
| macromolecular complex assembly | GO:0065003 | 256 | 0.021 | |
| positive regulation of signal transduction | GO:0009967 | 223 | 0.021 | |
| purine nucleotide catabolic process | GO:0006195 | 109 | 0.021 | |
| tripartite regional subdivision | GO:0007351 | 103 | 0.021 | |
| protein modification process | GO:0036211 | 438 | 0.021 | |
| regulation of histone modification | GO:0031056 | 20 | 0.021 | |
| regulation of response to stress | GO:0080134 | 200 | 0.021 | |
| regulation of molecular function | GO:0065009 | 217 | 0.020 | |
| dna damage checkpoint | GO:0000077 | 78 | 0.020 | |
| regulation of cell cycle process | GO:0010564 | 181 | 0.019 | |
| glial cell migration | GO:0008347 | 31 | 0.019 | |
| positive regulation of chromatin silencing | GO:0031937 | 16 | 0.019 | |
| regulation of cellular response to stress | GO:0080135 | 89 | 0.019 | |
| regulation of cell cycle | GO:0051726 | 291 | 0.019 | |
| dna alkylation | GO:0006305 | 4 | 0.019 | |
| muscle structure development | GO:0061061 | 224 | 0.019 | |
| asymmetric stem cell division | GO:0098722 | 49 | 0.018 | |
| regulation of cellular amine metabolic process | GO:0033238 | 3 | 0.018 | |
| purine ribonucleotide metabolic process | GO:0009150 | 145 | 0.018 | |
| mitotic g2 m transition checkpoint | GO:0044818 | 70 | 0.018 | |
| nucleoside catabolic process | GO:0009164 | 112 | 0.017 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 109 | 0.017 | |
| axis specification | GO:0009798 | 167 | 0.017 | |
| regulation of mitotic cell cycle | GO:0007346 | 190 | 0.017 | |
| single organism cellular localization | GO:1902580 | 180 | 0.017 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 174 | 0.017 | |
| rna localization | GO:0006403 | 115 | 0.016 | |
| negative regulation of cell cycle process | GO:0010948 | 109 | 0.016 | |
| chromosome segregation | GO:0007059 | 157 | 0.016 | |
| neuronal stem cell division | GO:0036445 | 35 | 0.016 | |
| cellular protein localization | GO:0034613 | 160 | 0.016 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 39 | 0.015 | |
| anterior posterior axis specification embryo | GO:0008595 | 103 | 0.015 | |
| peptidyl lysine methylation | GO:0018022 | 16 | 0.015 | |
| oocyte development | GO:0048599 | 124 | 0.015 | |
| ribose phosphate metabolic process | GO:0019693 | 145 | 0.014 | |
| phagocytosis | GO:0006909 | 215 | 0.014 | |
| morphogenesis of an epithelium | GO:0002009 | 276 | 0.014 | |
| positive regulation of organelle organization | GO:0010638 | 65 | 0.014 | |
| carbohydrate derivative catabolic process | GO:1901136 | 118 | 0.014 | |
| negative regulation of chromosome organization | GO:2001251 | 19 | 0.014 | |
| nucleoside metabolic process | GO:0009116 | 127 | 0.014 | |
| protein localization to organelle | GO:0033365 | 82 | 0.014 | |
| cell cycle phase transition | GO:0044770 | 140 | 0.014 | |
| organophosphate catabolic process | GO:0046434 | 112 | 0.013 | |
| muscle organ development | GO:0007517 | 127 | 0.013 | |
| protein dna complex subunit organization | GO:0071824 | 86 | 0.013 | |
| stem cell differentiation | GO:0048863 | 117 | 0.013 | |
| heterochromatin assembly | GO:0031507 | 13 | 0.013 | |
| single organism biosynthetic process | GO:0044711 | 206 | 0.013 | |
| negative regulation of erk1 and erk2 cascade | GO:0070373 | 3 | 0.013 | |
| nucleoside phosphate catabolic process | GO:1901292 | 110 | 0.013 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 152 | 0.012 | |
| developmental growth | GO:0048589 | 280 | 0.012 | |
| nucleotide metabolic process | GO:0009117 | 161 | 0.012 | |
| ribonucleotide catabolic process | GO:0009261 | 109 | 0.012 | |
| purine nucleoside catabolic process | GO:0006152 | 112 | 0.012 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 119 | 0.012 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 116 | 0.012 | |
| ribonucleoside metabolic process | GO:0009119 | 127 | 0.012 | |
| cellular response to organic substance | GO:0071310 | 132 | 0.012 | |
| purine containing compound metabolic process | GO:0072521 | 155 | 0.012 | |
| leg disc development | GO:0035218 | 92 | 0.012 | |
| glycosyl compound catabolic process | GO:1901658 | 112 | 0.012 | |
| negative regulation of signal transduction | GO:0009968 | 206 | 0.011 | |
| stem cell proliferation | GO:0072089 | 88 | 0.011 | |
| ribonucleotide metabolic process | GO:0009259 | 145 | 0.011 | |
| death | GO:0016265 | 284 | 0.011 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 108 | 0.011 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 108 | 0.011 | |
| dendrite morphogenesis | GO:0048813 | 199 | 0.011 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 108 | 0.011 | |
| dna dependent dna replication | GO:0006261 | 17 | 0.011 | |
| positive regulation of protein metabolic process | GO:0051247 | 128 | 0.011 | |
| organelle assembly | GO:0070925 | 198 | 0.011 | |
| organonitrogen compound catabolic process | GO:1901565 | 128 | 0.011 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 36 | 0.011 | |
| negative regulation of response to stimulus | GO:0048585 | 258 | 0.011 | |
| dna methylation | GO:0006306 | 4 | 0.011 | |
| tissue death | GO:0016271 | 102 | 0.011 | |
| nuclear division | GO:0000280 | 332 | 0.010 | |
| peptidyl lysine trimethylation | GO:0018023 | 6 | 0.010 | |
| regulation of protein modification process | GO:0031399 | 112 | 0.010 | |
| cell death | GO:0008219 | 279 | 0.010 | |
| meiotic dna double strand break formation involved in reciprocal meiotic recombination | GO:0010780 | 1 | 0.010 | |
| germarium derived oocyte differentiation | GO:0030706 | 29 | 0.010 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 242 | 0.010 | |
| meiotic nuclear division | GO:0007126 | 151 | 0.010 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 151 | 0.010 | |
| regulation of cellular localization | GO:0060341 | 136 | 0.010 | |
| response to abiotic stimulus | GO:0009628 | 341 | 0.010 | |
